title: Clarification on Tartari et al.: Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients.
authors.affiliation: Merck & Co., Inc., 2000 Galloping Hill Rd., Kenilworth, NJ 07033, USA. Electronic address: thomas_burke2@merck.com.
authors.forename: Thomas
authors.initials: T
authors.lastname: Burke
mesh_terms: D006801:Humans; D009369:Neoplasms